tirzepatide red spot at injection site Tirzepatide-Induced Reaction Managing Injection Site Reactions with

Both programs exclusively used once-weekly dosing

If dizziness persists despite appropriate management strategies, further investigation may be warranted to exclude other causes unrelated to the medication itself

For type 2 diabetes, transitioning to metformin, SGLT2 inhibitors, or other agents may provide adequate glycemic control in some patients, though typically with less weight loss benefit

This oligomeric state affects SEC analysis, where the protein runs at a higher apparent molecular weight than the monomer mass suggests, and must be taken into account when interpreting aggregation data

The baseline utility value for obesity was set at 0.80 quality-adjusted life-years (QALYs)